InfuSystem Holdings (INFU) Capital Expenditures Growth (5y) (2015 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | InfuSystem Holdings | 189.28 Mn | 187.17 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.45% |
| Dec 31, 2025 | 105.94% |
| Sep 30, 2025 | 16.43% |
| Jun 30, 2025 | 48.13% |
| Mar 31, 2025 | -27.57% |
| Dec 31, 2024 | -18.27% |
| Sep 30, 2024 | -127.65% |
| Jun 30, 2024 | 17.88% |
| Mar 31, 2024 | -16.07% |
| Dec 31, 2023 | 13.49% |
| Sep 30, 2023 | 0.36% |
| Jun 30, 2023 | -35.80% |
| Mar 31, 2023 | -22.31% |
| Dec 31, 2022 | 19.64% |
| Sep 30, 2022 | -10.02% |
| Jun 30, 2022 | -15.16% |
| Mar 31, 2022 | -47.37% |
| Dec 31, 2021 | 16.31% |
| Sep 30, 2021 | -4.08% |
| Jun 30, 2021 | -40.41% |